Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Efficacy of the Two-point Method in Percutaneous Transhepatic Choledoscopy and the Influence of the Long-term Recurrence of Hepatolithiasis

NCT06839612 is registered in ClinicalTrials.gov with Shengjing Hospital as lead sponsor.

NCT NCT06839612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06839612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Efficacy of the Two-point Method in Percutaneous Transhepatic Choledoscopy and the Influence of the Long-term Recurrence of Hepatolithiasis
Lead sponsor
Shengjing Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2013
Completion date
January 20, 2025
Enrollment
157 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

endoscopy, digestive system, hepatolithiasis